DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 203186
The generic ingredient in ZOLMITRIPTAN is zolmitriptan. There are twenty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
Summary for 203186
Tradename: | ZOLMITRIPTAN |
Applicant: | Mylan Pharms Inc |
Ingredient: | zolmitriptan |
Patents: | 0 |
Therapeutic Class: | Antimigraine Agents |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 203186
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 203186
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 203186 | ANDA | Mylan Pharmaceuticals Inc. | 0378-4260 | N | 0378-4260-56 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | May 14, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | May 14, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription